Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination
Global concerns arose as the emerged and rapidly spreading SARS-CoV-2 variants might escape host immunity induced by vaccination. In this study, a heterologous prime-boost immunization strategy for COVID-19 was designed to prime with a DNA vaccine encoding wild type (WT) spike protein receptor-bindi...
Main Authors: | Yuxin Chen, Liguo Zhu, Weijin Huang, Xin Tong, Hai Wu, Yue Tao, Bei Tong, Haibin Huang, Jiachen Chen, Xiangan Zhao, Yang Lou, Chao Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2021.1942227 |
Similar Items
-
Monoclonal Antibody Therapies against Anthrax
by: Zhaochun Chen, et al.
Published: (2011-08-01) -
An Anti-CD7 Antibody–Drug Conjugate Target Showing Potent Antitumor Activity for T-Lymphoblastic Leukemia (T-ALL)
by: Shiqi Wang, et al.
Published: (2024-01-01) -
Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience
by: Bianca Raffaelli, et al.
Published: (2023-02-01) -
The generation of hemagglutinin monoclonal antibodies against H9N2 influenza virus
by: Yongcheng Duan, et al.
Published: (2023-11-01) -
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
by: Pardis Mokhtary, et al.
Published: (2022-08-01)